Functional associations of genetic variants involved in the clinical manifestation of erythropoietic protoporphyria in the Argentinean population

Authors

  • F.P. Colombo,

    1. Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP) –CONICET, Hospital de Clínicas “José de San Martín”-UBA, Av. Córdoba 2351, 1º subsuelo, Buenos Aires, Argentina (1120)
    2. Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales-Universidad de Buenos Aires. Ciudad Universitaria, Buenos Aires, Argentina
    Search for more papers by this author
  • M.V. Rossetti,

    1. Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP) –CONICET, Hospital de Clínicas “José de San Martín”-UBA, Av. Córdoba 2351, 1º subsuelo, Buenos Aires, Argentina (1120)
    2. Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales-Universidad de Buenos Aires. Ciudad Universitaria, Buenos Aires, Argentina
    Search for more papers by this author
  • M. Méndez,

    1. Centro de Investigación, Hospital 12 de Octubre, Universidad Complutense de Madrid. Av. de Córdoba s/n. (28041), Madrid, España
    Search for more papers by this author
  • J.E. Martínez,

    1. Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP) –CONICET, Hospital de Clínicas “José de San Martín”-UBA, Av. Córdoba 2351, 1º subsuelo, Buenos Aires, Argentina (1120)
    2. Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales-Universidad de Buenos Aires. Ciudad Universitaria, Buenos Aires, Argentina
    Search for more papers by this author
  • R. Enríquez de Salamanca,

    1. Centro de Investigación, Hospital 12 de Octubre, Universidad Complutense de Madrid. Av. de Córdoba s/n. (28041), Madrid, España
    Search for more papers by this author
  • A.M. del C. Batlle,

    1. Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP) –CONICET, Hospital de Clínicas “José de San Martín”-UBA, Av. Córdoba 2351, 1º subsuelo, Buenos Aires, Argentina (1120)
    Search for more papers by this author
  • V.E. Parera

    Corresponding author
    1. Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP) –CONICET, Hospital de Clínicas “José de San Martín”-UBA, Av. Córdoba 2351, 1º subsuelo, Buenos Aires, Argentina (1120)
    2. Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales-Universidad de Buenos Aires. Ciudad Universitaria, Buenos Aires, Argentina
    Search for more papers by this author

  • Conflict of interest
    The authors declare that they have no competing interests as defined by the Journal of the European Academy of Dermatology and Venereology, or other interests that might be perceived to influence the results and discussion reported in this paper.

V.E. Parera. E-mail:vicky@qb.fcen.uba.ar

Abstract

Background  Combined inheritance of genetic variants in ferrochelatase gene (FECH) are implicated in clinical manifestation of Erythropoietic Protoporphyria (EPP).

Objective  Identify the genetic variants in FECH gene and their associations in the expression of EPP in Argentina. Determine the allelic frequency of polymorphic variants, associations in cis and its linkage disequilibrium.

Methods  The FECH gene was PCR-amplified and sequenced. Allelic variants of intragenic polymorphisms were identified by PCR followed by sequencing or restriction digestion analysis. Residual FECH activity was determined by prokaryotic expression in Escherichia coli JM109. Data were analyzed using Haploview and Statistix 9.

Results  Ten mutations were identified: three novel (p.S222N; p.R298X and p.R367X) and seven already known (g.12490_18067del; p.R115X; p.I186T; c.580_584delTACAG; c.598 + 1 G>T; p.Y209X and p.W310X). The p.R115X mutation was found in two families. The p.S222N mutation expressed 5% of normal activity. Only individuals who inherited a mutation combined in trans to a low expression allele c.1-251G, c.68-23T, and c.315-48C, showed clinical symptoms. The absence of c.315-48C variant was sufficient for not triggering EPP. However, these variants showed high levels of cosegregation and GTC haplotype is over-represented in EPP patients.

Conclusion  In the dominant inheritance form of EPP, c.315-48C variant in trans to the mutated allele is sufficient to trigger the disease. The presence of GTC haplotype in all patients with dominant EPP could be due to the high level of cosegregation of c.315-48C with c.1-251G and c.68-23T variants in our population.

Ancillary